A new treatment option is available for patients with chronic obstructive pulmonary disease. This option combines three active ingredients and is designed for long-term management of moderate to severe cases. The treatment is administered twice daily and comes in a single strength.

Regulatory approval was granted by the Drug Controller General of India, allowing the treatment to be launched. This launch marks an expansion of available treatments for patients.

Further details about this new treatment option are available, including information about the company behind its launch and the impact on the market.